Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Ceftolozane/Tazobactam in Burn Patients
NCT03002506Phase 4Terminated
- Sponsor
- Texas Tech University Health Sciences Center
- Start
- Aug 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ceftolozane + tazobactam in bacterial infection, sponsored by Texas Tech University Health Sciences Center. Primary endpoint: Ceftolozane Clearance at 24 hours. Started Aug 2017; status: terminated.
02
Drugs
ceftolozane + tazobactam
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT03002506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03002506.